How should Cadzyme syrup (pancreatic enzyme replacement) be dosed and administered in infants and children, including weight‑based dosing, maximum daily limits, and monitoring?

Cadzyme Syrup Dosing and Administration in Infants and Children

For infants and children with pancreatic insufficiency requiring Cadzyme (pancreatic enzyme replacement therapy), start with 500 units of lipase per kg per meal and 250 units of lipase per kg per snack, with a strict maximum daily limit of 10,000 units of lipase per kg per day or 2,500 units per kg per meal to avoid fibrosing colonopathy. 1

Weight-Based Dosing Algorithm

Starting Doses

• Meals: 500 units lipase/kg/meal
• Snacks: 250 units lipase/kg/snack
• Example: For a 10 kg infant, start with 5,000 units lipase per meal and 2,500 units per snack 1

Titration Strategy

If symptoms of maldigestion (steatorrhea, diarrhea, abdominal distention, poor weight gain) persist:

• Increase dose gradually by 500 units lipase/kg/meal increments
• Reassess response after each adjustment
• Continue titrating until symptoms resolve 1

Absolute Maximum Daily Limits

Critical Safety Threshold: Never exceed 10,000 units of lipase/kg/day total or 2,500 units of lipase/kg/meal 1. This upper limit is non-negotiable due to the strong association between high-dose PERT (>24,000 units/kg/day) and fibrosing colonopathy in children, with relative risk increasing dramatically to 199.5 at doses exceeding 50,000 units/kg/day 2.

Evidence on Dosing Efficacy in Infants

Research shows that higher initial PERT doses (>1,500 units lipase/kg/largest meal) correlate with better weight outcomes at 2 years (adjusted OR 1.87 for achieving birth weight z-score) 3. However, studies in infants 6-30 months demonstrate that 500 units lipase/kg/meal achieves approximately 89% coefficient of fat absorption, with no clear benefit from higher doses in this age group 4. The average dose used in clinical practice ranges from 1,842-1,882 units lipase/kg/meal during the first year of life 5.

Administration Technique for Infants

Since infants cannot swallow capsules whole:

• Open the capsule and mix the microtablets/beads with a small amount of applesauce
• Administer immediately; do not store mixed medication
• Give with each meal and snack containing fat
• Do not crush or chew the enzyme beads (destroys enteric coating)

Monitoring Requirements

Clinical Monitoring

• Growth parameters: Weight, length, weight-for-length percentile at each visit
• Stool patterns: Frequency, consistency, presence of undigested food or oil
• Gastrointestinal symptoms: Abdominal pain, distention, flatulence

Laboratory Monitoring

• Annual micronutrient assessment: Fat-soluble vitamins (A, D, E, K)
• Endocrine function: Glucose, HgbA1C annually 1
• Bone density: DEXA scan every 2 years 1

When to Reassess Dosing

If symptoms persist despite adequate dosing:

• Verify proper administration technique
• Consider acid suppression therapy (proton pump inhibitors may improve weight gain by 0.37 z-score compared to H2-blockers) 5
• Rule out alternative diagnoses: celiac disease, small intestinal bacterial overgrowth, inflammatory bowel disease 1
• Confirm diagnosis with fecal elastase testing if not previously done

Critical Pitfalls to Avoid

Overdosing Risk: The historical case-control study definitively established that doses >24,000 units/kg/day carry a 10.9-fold increased risk of fibrosing colonopathy, escalating to nearly 200-fold at doses >50,000 units/kg/day 2. This complication requires colectomy and occurs primarily in young children.

Underdosing: Many patients receive inadequate PERT, leading to malnutrition and poor growth 6. Don't hesitate to titrate upward within safe limits if symptoms persist.

Inadequate Mixing: Enzymes must mix properly with food in the stomach. Consider acid suppression if response is suboptimal despite adequate dosing 5.

Special Populations

Preterm Infants

For preterm infants with growth failure and low fecal pancreatic elastase-1 (<200 μg/g), digestive enzyme replacement at 6,000 units lipase/kg/day and 240 units protease/kg/day via gavage significantly improves weight gain from 14.4 to 17.4 g/kg/day 7.

Pregnancy and Nursing Considerations

Per FDA labeling, consult a healthcare professional before use if pregnant or nursing 8. Keep out of reach of children 8.